Some members of Congress are considering a drug pricing plan, known as H.R. 3, that could have devastating effects for Americans. Proponents of the bill have painted a misleading picture and overlooked the significant negative consequences H.R. 3 could have for patients and our economy if implemented.

We have to lower what patients pay for their medicines and make sure they are getting the medicines they need. There’s a way to do both, but H.R. 3 isn’t it.

Learn more in this fact sheet from PhRMA.